Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer

Open access
Neskey, David M., Osman, Abdullah A., Ow, Thomas J., Katsonis, Panagiotis, McDonald, Thomas, Hicks, Stephanie C., Hsu, Teng-Kuei, Pickering, Curtis R., Ward, Alexandra, Patel, Ameeta, Yordy, John S., Skinner, Heath D., Giri, Uma, Sano, Daisuke, Story, Michael D., Beadle, Beth M., El-Naggar, Adel K., Kies, Merrill S., William, William N., Caulin, Carlos, Frederick, Mitchell, Kimmel, Marek, Myers, Jeffrey N., Lichtarge, Olivier·2015·Cancer Research

Abstract

TP53 is the most frequently altered gene in head and neck squamous cell carcinoma, with mutations occurring in over two-thirds of cases, but the prognostic significance of these mutations remains elusive. In the current study, we evaluated a novel computational approach termed evolutionary action (EAp53) to stratify patients with tumors harboring TP53 mutations as high or low risk, and validated this system in both in vivo and in vitro models. Patients with high-risk TP53 mutations had the poorest survival outcomes and the shortest time to the development of distant metastases. Tumor cells expressing high-risk TP53 mutations were more invasive and tumorigenic and they exhibited a higher incidence of lung metastases. We also documented an association between the presence of high-risk mutations and decreased expression of TP53 target genes, highlighting key cellular pathways that are likely to be dysregulated by this subset of p53 mutations that confer particularly aggressive tumor behavior. Overall, our work validated EAp53 as a novel computational tool that may be useful in clinical prognosis of tumors harboring p53 mutations. Cancer Res; 75(7); 1527–36. ©2015 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-2735

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 158

Metadata

Authors
Neskey, D. M., Osman, A. A., Ow, T. J., Katsonis, P., McDonald, T., Hicks, S. C., Hsu, T.-K., Pickering, C. R., Ward, A., Patel, A., Yordy, J. S., Skinner, H. D., Giri, U., Sano, D., Story, M. D., Beadle, B. M., El-Naggar, A. K., Kies, M. S., William, W. N., Caulin, C., Frederick, M., Kimmel, M., Myers, J. N., & Lichtarge, O.
Venue
Cancer Research
Published
2015-03-31
Volume
75
Issue
7
Pages
1527-1536
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W1976366656
Cited by
158
References
4
FWCI
6.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-2735
The paper
Neskey, D. M., Osman, A. A., Ow, T. J., Katsonis, P., McDonald, T., Hicks, S. C., Hsu, T.-K., Pickering, C. R., Ward, A., Patel, A., Yordy, J. S., Skinner, H. D., Giri, U., Sano, D., Story, M. D., Beadle, B. M., El-Naggar, A. K., Kies, M. S., William, W. N., . . . Lichtarge, O. (2015). Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-2735

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.